Covid-19 roundup: Re­gen­eron's mAB gets ex­pand­ed EUA; mR­NA drug­mak­ers spike price of vac­cines in EU sup­ply deal

The FDA has ex­pand­ed the au­tho­riza­tion for Re­gen­eron’s Covid-19 treat­ment Re­gen-Cov in an an­nounce­ment Fri­day.

The au­tho­riza­tion now cov­ers post-ex­po­sure pro­phy­lax­is …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER